These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10866126)

  • 1. Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection.
    Folwaczny C; Loeschke K; Schnettler D; Jäger G; Wiebecke B; Hoelscher M; Sauer T; König A; Endres SP; Fricke H
    Clin Immunol; 2000 Jun; 95(3):197-202. PubMed ID: 10866126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
    Griga T; Hebler U; Voigt E; Tromm A; May B
    Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics.
    Tillinger W; Jilch R; Jilma B; Brunner H; Koeller U; Lichtenberger C; Waldhör T; Reinisch W
    Am J Gastroenterol; 2009 Jan; 104(1):102-9. PubMed ID: 19098857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early measles virus infection is associated with the development of inflammatory bowel disease.
    Pardi DS; Tremaine WJ; Sandborn WJ; Loftus EV; Poland GA; Harmsen WS; Zinsmeister AR; Melton LJ
    Am J Gastroenterol; 2000 Jun; 95(6):1480-5. PubMed ID: 10894583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of endothelial dysfunction in patients with inflammatory bowel disease.
    Roifman I; Sun YC; Fedwick JP; Panaccione R; Buret AG; Liu H; Rostom A; Anderson TJ; Beck PL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):175-82. PubMed ID: 19121648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of 4C8 antigen, a novel transendothelial migration-associated molecule on activated T lymphocytes, in inflammatory bowel disease.
    Oshitani N; Hato F; Kitagawa S; Masuyama J; Higuchi K; Matsumoto T; Arakawa T
    J Pathol; 2002 Aug; 197(5):589-94. PubMed ID: 12210077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes.
    Afzal MA; Armitage E; Begley J; Bentley ML; Minor PD; Ghosh S; Ferguson A
    J Med Virol; 1998 Jul; 55(3):243-9. PubMed ID: 9624614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation.
    Lin P; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2006 Jun; 141(6):1097-104. PubMed ID: 16765679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O; Kaser A; Tilg H
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
    Sasaki N; Kurose A; Inoue H; Sawai T
    Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
    Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
    Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.